Send feedback

F9 p.Arg75Gln

c.224G>A · rs137852228 · VCV10573

Pathogenic Expert panel
Classification
Pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 10 submitters
AlphaMissense
likely benign
0.1299 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00217%, amr)
Missense predictors
2/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
3
hemophilia B

ClinGen expert panel — Coagulation Factor Deficiency VCEP

Pathogenic for hemophilia B. Applied ACMG criteria (verbatim):

PP4_Moderate PS4_VeryStrong PM2_Supporting PP3

Curation rationale (ClinGen, verbatim)

NM_000133.4(F9):c.224G>A (p.Arg75Gln) missense variant has a REVEL score of 0.904, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). Approximately 24 patients are reported in the literature with mild hemophilia B and this variant, meeting F9 phenotype criteria for PS4_Very strong (PMID: 31064749, PMID: 2066105, PMID: 8314564, PMID: 29296726, PMID: 27213901, PMID: 2773937). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very strong, PP4_Moderate, PP3, PM2_supporting.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.1299likely benign ⚠ discordant with ClinVar
REVEL0.904moderately pathogenic-leaning
SaProtLLR -11.24damaging
⇒ REVEL and SaProt call this damaging; AlphaMissense does not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 9.8GERP 4.3, phastCons 1
Regional constrainto/e 0.57unconstrained · MANE · 25 kb · p 2.3e-14 · regional, not allelic
Overall
CADD25.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00217% Admixed American · 1/45,990 alleles
Filtering AF 8.9e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 2.5e-05%
Overall 0.000364% 4/1,097,542 alleles · very rare
Ancestry group Frequency 1 in
Admixed Americangrpmax 0.00217% 45,990
European (non-Finnish) 0.000335% 298,354

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
F9
Protein
p.Arg75Gln
Coding
c.224G>A
MANE Select
NM_000133
dbSNP
rs137852228
Type
single nucleotide variant
Location
chrX:139537145 (GRCh38)
Structure
AlphaFold pLDDT 80.45 · 57 PDB
Residue 75
a UniProt-annotated variant site (in hemb; mild); an α-helix; the gla domain
Full F9 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hemophilia B — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: thrombophilia, X-linked, due to factor 9 defecthemophilia A

For Hemophilia B (Orphanet):

Inheritance
X-linked recessive
Onset
Childhood, Infancy, Neonatal
Prevalence
1-9 / 100 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/f9-p-arg75gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown